|
CA2451493C
(en)
|
2001-06-22 |
2016-08-23 |
Chugai Seiyaku Kabushiki Kaisha |
Cell growth inhibitors containing anti-glypican 3 antibody
|
|
JP5139800B2
(ja)
*
|
2004-06-03 |
2013-02-06 |
ノビミューン エスアー |
抗ｃｄ３抗体およびその使用方法
|
|
CN1842540B
(zh)
|
2004-07-09 |
2012-07-04 |
中外制药株式会社 |
抗-磷脂酰肌醇蛋白聚糖3抗体
|
|
AU2005336093B2
(en)
|
2004-10-08 |
2011-02-24 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Adoptive immunotherapy with enhanced T lymphocyte survival
|
|
CN101068836B
(zh)
|
2004-10-26 |
2013-08-14 |
中外制药株式会社 |
糖链改变的抗磷脂酰肌醇聚糖3抗体
|
|
US20070087005A1
(en)
|
2005-10-14 |
2007-04-19 |
Lazar Gregory A |
Anti-glypican-3 antibody
|
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
|
WO2010042490A1
(en)
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
A single lentiviral vector system for induced pluripotent (ips) stem cells derivation
|
|
WO2010088160A1
(en)
|
2009-01-28 |
2010-08-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors and related materials and methods of use
|
|
CN103635573B
(zh)
|
2011-05-19 |
2016-05-11 |
分子医学研究所 |
包含γδT细胞的淋巴细胞系、其组合物及生产方法
|
|
WO2013070468A1
(en)
*
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
CN103833852A
(zh)
*
|
2012-11-23 |
2014-06-04 |
上海市肿瘤研究所 |
针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体
|
|
CN104140974B
(zh)
|
2013-05-08 |
2017-09-29 |
科济生物医药（上海）有限公司 |
编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞
|
|
JP2016539929A
(ja)
*
|
2013-10-25 |
2016-12-22 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫療法のためのポリクローナルγδＴ細胞
|
|
GB201506423D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
CN107075480A
(zh)
|
2014-07-09 |
2017-08-18 |
Tc生物制药有限公司 |
γδT细胞及其用途
|
|
US10093746B2
(en)
|
2014-09-04 |
2018-10-09 |
The Trustees Of The University Of Pennsylvania |
Glypican-3 antibody and uses thereof
|
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
|
JP2017529851A
(ja)
|
2014-09-26 |
2017-10-12 |
ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ |
養子免疫療法のためのグリピカン−３特異的キメラ抗原レセプター
|
|
WO2016081518A2
(en)
|
2014-11-17 |
2016-05-26 |
Adicet Bio, Inc. |
Engineered gamma delta t-cells
|
|
CN105713881B
(zh)
|
2014-12-04 |
2019-12-06 |
科济生物医药（上海）有限公司 |
双靶向gpc3和asgpr1的转基因免疫效应细胞及其应用
|
|
GB201507368D0
(en)
*
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
NL2014935B1
(en)
*
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
AU2016274633B2
(en)
|
2015-06-09 |
2022-04-21 |
Gammadelta Therapeutics Ltd |
Methods for the production of TCR gamma delta+ T cells
|
|
US12168061B2
(en)
*
|
2015-08-03 |
2024-12-17 |
Crage Medical Co., Limited |
Antibody against glypican-3 and application thereof
|
|
US20180258149A1
(en)
*
|
2015-09-17 |
2018-09-13 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
KR20190003938A
(ko)
*
|
2016-02-25 |
2019-01-10 |
셀 메디카 스위처란트 아게 |
면역치료를 위한 변형된 세포
|
|
EP3454870A4
(en)
*
|
2016-05-12 |
2020-03-04 |
Adicet Bio Inc. |
METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF
|
|
CN107523545A
(zh)
*
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的杀伤性细胞及其用途
|
|
US20190262397A1
(en)
*
|
2016-07-26 |
2019-08-29 |
Tessa Therapeutics Pte. Ltd. |
Chimeric antigen receptor
|
|
BR112019013947A2
(pt)
*
|
2017-01-10 |
2020-02-11 |
Yamaguchi University |
Anticorpo, receptor de antígeno quimérico, célula imunocompetente, gene de anticorpo, vetor, célula hospedeira, método para detectar gpc3, e, kit para a detecção de gpc3.
|
|
GB201701332D0
(en)
*
|
2017-01-26 |
2017-03-15 |
Tc Biopharm Ltd |
Immune cells with modified metabolism and their use thereof
|
|
EP3580331B1
(en)
*
|
2017-02-08 |
2022-06-01 |
Agency For Science, Technology And Research |
Gamma delta t cells and a method of augmenting the tumoricidal activity of the same
|
|
IL270138B2
(en)
*
|
2017-04-26 |
2025-08-01 |
Eureka Therapeutics Inc |
Structures that specifically recognize glypican 3 and their uses
|
|
GB2562774A
(en)
|
2017-05-25 |
2018-11-28 |
Mcdonald Michael |
Genetic construct
|
|
AU2017418590A1
(en)
*
|
2017-06-14 |
2020-01-16 |
Adicet Therapeutics, Inc. |
Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof
|
|
EP3561053A1
(en)
*
|
2018-04-26 |
2019-10-30 |
Baylor College of Medicine |
Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
|
|
EP3784256A4
(en)
*
|
2018-04-27 |
2022-06-29 |
Baylor College of Medicine |
Car t cells with one or more interleukins
|
|
CN108588023B
(zh)
*
|
2018-05-09 |
2020-02-14 |
河北森朗生物科技有限公司 |
一种生产嵌合抗原受体修饰的γδT细胞的方法
|
|
JPWO2020017479A1
(ja)
*
|
2018-07-17 |
2021-08-02 |
ノイルイミューン・バイオテック株式会社 |
抗ｇｐｃ３一本鎖抗体を含むｃａｒ
|